• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性醛固酮增多症中的心血管风险

Cardiovascular Risk in Primary Hyperaldosteronism.

作者信息

Prejbisz A, Warchoł-Celińska E, Lenders J W M, Januszewicz A

机构信息

Department of Hypertension, Institute of Cardiology, Warsaw, Poland.

Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.

出版信息

Horm Metab Res. 2015 Dec;47(13):973-80. doi: 10.1055/s-0035-1565124. Epub 2015 Nov 17.

DOI:10.1055/s-0035-1565124
PMID:26575306
Abstract

After the first cases of primary aldosteronism were described and characterized by Conn, a substantial body of experimental and clinical evidence about the long-term effects of excess aldosterone on the cardiovascular system was gathered over the last 5 decades. The prevalence of primary aldosteronism varies considerably between different studies among hypertensive patients, depending on patient selection, the used diagnostic methods, and the severity of hypertension. Prevalence rates vary from 4.6 to 16.6% in those studies in which confirmatory tests to diagnose primary aldosteronism were used. There is also growing evidence indicating that prolonged exposure to elevated aldosterone concentrations is associated with target organ damage in the heart, kidney, and arterial wall, and high cardiovascular risk in patients with primary aldosteronism. Therefore, the aim of treatment should not be confined to BP normalization and hypokalemia correction, but rather should focus on restoring the deleterious effects of excess aldosterone on the cardiovascular system. Current evidence convincingly demonstrates that both surgical and medical treatment strategies beneficially affect cardiovascular outcomes and mortality in the long term. Further studies can be expected to provide better insight into the relationship between cardiovascular risk and complications and the genetic background of primary aldosteronism.

摘要

在原发性醛固酮增多症的首批病例被康恩描述并确定其特征之后,在过去50年里积累了大量关于醛固酮过量对心血管系统长期影响的实验和临床证据。在高血压患者中,不同研究之间原发性醛固酮增多症的患病率差异很大,这取决于患者的选择、所使用的诊断方法以及高血压的严重程度。在那些使用确诊试验来诊断原发性醛固酮增多症的研究中,患病率从4.6%到16.6%不等。也有越来越多的证据表明,长期暴露于升高的醛固酮浓度与心脏、肾脏和动脉壁的靶器官损害以及原发性醛固酮增多症患者的高心血管风险有关。因此,治疗的目标不应局限于血压正常化和低钾血症的纠正,而应侧重于恢复醛固酮过量对心血管系统的有害影响。目前的证据令人信服地表明,手术和药物治疗策略从长期来看都对心血管结局和死亡率有有益影响。预计进一步的研究能够更深入地了解心血管风险和并发症之间的关系以及原发性醛固酮增多症的遗传背景。

相似文献

1
Cardiovascular Risk in Primary Hyperaldosteronism.原发性醛固酮增多症中的心血管风险
Horm Metab Res. 2015 Dec;47(13):973-80. doi: 10.1055/s-0035-1565124. Epub 2015 Nov 17.
2
Cardiovascular outcomes in patients with primary aldosteronism after treatment.原发性醛固酮增多症患者治疗后的心血管结局
Arch Intern Med. 2008 Jan 14;168(1):80-5. doi: 10.1001/archinternmed.2007.33.
3
Comorbidities in primary aldosteronism.原发性醛固酮增多症的合并症。
Horm Metab Res. 2010 Jun;42(6):429-34. doi: 10.1055/s-0029-1243257. Epub 2010 Jan 4.
4
Salt Appetite and its Effects on Cardiovascular Risk in Primary Aldosteronism.盐欲及其对原发性醛固酮增多症心血管风险的影响。
Horm Metab Res. 2020 Jun;52(6):386-393. doi: 10.1055/a-1116-2407. Epub 2020 Apr 6.
5
Hypertension caused by primary hyperaldosteronism: increased heart damage and cardiovascular risk.原发性醛固酮增多症所致高血压:心脏损害增加及心血管风险升高。
Rev Esp Cardiol (Engl Ed). 2013 Jan;66(1):47-52. doi: 10.1016/j.recesp.2012.07.025. Epub 2012 Nov 13.
6
Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.新加坡亚洲高血压患者中原发性醛固酮增多症的患病率。
J Clin Endocrinol Metab. 2000 Aug;85(8):2854-9. doi: 10.1210/jcem.85.8.6752.
7
The cardiovascular consequences of hyperaldosteronism.醛固酮增多症的心血管后果。
Ann Endocrinol (Paris). 2021 Jun;82(3-4):174-178. doi: 10.1016/j.ando.2020.02.006. Epub 2020 Feb 28.
8
Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.原发性醛固酮增多症患者中心血管疾病及其危险因素的流行情况:日本多中心研究。
Hypertension. 2018 Mar;71(3):530-537. doi: 10.1161/HYPERTENSIONAHA.117.10263. Epub 2018 Jan 22.
9
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment.原发性醛固酮增多症中的肾囊肿与低钾血症:治疗后的长期随访结果
J Hypertens. 2007 Jul;25(7):1443-50. doi: 10.1097/HJH.0b013e328126855b.
10
Primary aldosteronism: an update on screening, diagnosis and treatment.原发性醛固酮增多症:筛查、诊断及治疗的最新进展
J Hypertens. 2008 Apr;26(4):613-21. doi: 10.1097/HJH.0b013e3282f4b3e6.

引用本文的文献

1
A predictive nomogram for incomplete clinical success after unilateral adrenalectomy in patients with primary aldosteronism.原发性醛固酮增多症患者单侧肾上腺切除术后不完全临床成功的预测列线图。
Front Endocrinol (Lausanne). 2025 Jul 24;16:1628564. doi: 10.3389/fendo.2025.1628564. eCollection 2025.
2
Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism.原发性醛固酮增多症的筛查与诊断。参与原发性醛固酮增多症管理的所有西班牙学会的共识文件。
Endocrine. 2024 Jul;85(1):99-121. doi: 10.1007/s12020-024-03751-1. Epub 2024 Mar 6.
3
Effect of Obesity on Clinical Characteristics of Primary Aldosteronism Patients at Diagnosis and Postsurgical Response.
肥胖对原发性醛固酮增多症患者诊断时临床特征及术后反应的影响。
J Clin Endocrinol Metab. 2023 Dec 21;109(1):e379-e388. doi: 10.1210/clinem/dgad400.
4
Risky business: a single-centre cross-sectional analysis of calculated cardiovascular risk in patients with primary aldosteronism and essential hypertension.高风险业务:原发性醛固酮增多症和原发性高血压患者计算心血管风险的单中心横断面分析。
BMJ Open. 2022 Nov 14;12(11):e062406. doi: 10.1136/bmjopen-2022-062406.
5
Genome-wide association study of hyperthyroidism based on electronic medical record from Taiwan.基于台湾电子病历的甲状腺功能亢进症全基因组关联研究。
Front Med (Lausanne). 2022 Jul 27;9:830621. doi: 10.3389/fmed.2022.830621. eCollection 2022.
6
Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight.原发性醛固酮增多症与难治性高血压:病理生理学新视角。
Int J Mol Sci. 2022 Apr 27;23(9):4803. doi: 10.3390/ijms23094803.
7
Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism.原发性醛固酮增多症中的脑血管心血管风险、靶器官损害及治疗结果
Front Cardiovasc Med. 2022 Feb 2;8:798364. doi: 10.3389/fcvm.2021.798364. eCollection 2021.
8
Primary aldosteronism is highly prevalent in patients with hypertension and moderate to severe obstructive sleep apnea.原发性醛固酮增多症在高血压合并中重度阻塞性睡眠呼吸暂停患者中高发。
J Clin Sleep Med. 2021 Apr 1;17(4):629-637. doi: 10.5664/jcsm.8960.
9
Conned by Conn's: The Manifestation of Conn's Syndrome Post-renal Transplant in a Patient with Polycystic Kidney Disease.
Cureus. 2020 Apr 2;12(4):e7512. doi: 10.7759/cureus.7512.
10
Effects of Primary Aldosteronism and Different Therapeutic Modalities on Glucose Metabolism.原发性醛固酮增多症及不同治疗方式对糖代谢的影响。
J Clin Med. 2019 Dec 12;8(12):2194. doi: 10.3390/jcm8122194.